Pharmaceutical Solutions
Showing 3351 - 3362 of 3,362
Eye Infection, Infection Trial in Boston (Moxifloxacin ophthalmic solution 0.5%, Gatifloxacin ophthalmic solution 0.3%)
Unknown status
- Eye Infection
- Infection
- Moxifloxacin ophthalmic solution 0.5%
- Gatifloxacin ophthalmic solution 0.3%
-
Boston, MassachusettsOphthalmic Consultants of Boston
Jul 3, 2006
Ametropia Trial in Waterloo (soft contact lens, Soft contact lens multipurpose disinfection regimen)
Completed
- Ametropia
- soft contact lens
- Soft contact lens multipurpose disinfection regimen
-
Waterloo, Ontario, CanadaCentre for Contact Lens Research, University of Waterloo
Jul 17, 2006
Myopia Trial in Waterloo (soft contact lens, Marketed multipurpose disinfection regimen)
Completed
- Myopia
- soft contact lens
- Marketed multipurpose disinfection regimen
-
Waterloo, Ontario, CanadaCentre for Contact Lens Research, University of Waterloo
Jul 5, 2006
ESRD Trial in Detroit (Gentamycin/citrate, Minocycline/EDTA)
Completed
- ESRD
- Gentamycin/citrate, Minocycline/EDTA
-
Detroit, MichiganHenry Ford Hospital
Feb 21, 2006
Cystic Fibrosis Trial in Chapel Hill (7% NaCl, Amiloride HCl)
Completed
- Cystic Fibrosis
- 7% NaCl
- Amiloride HCl
-
Chapel Hill, North CarolinaUniversity of North Carolina
Jan 9, 2006
Heparin-Induced Thrombocytopenia in Cardiovascular Patients
Unknown status
- Heparin-Induced Thrombocytopenia
-
Nagoya, Aichi, Japan
- +12 more
Feb 15, 2006
Acne Vulgaris, Acne, Propionibacterium Acnes Trial (MBI 226 Acne Solutions)
Completed
- Acne Vulgaris
- +2 more
- MBI 226 Acne Solutions
- (no location specified)
Sep 13, 2005
Acne Vulgaris, Acne, Propionibacterium Acnes Trial (MBI 226 Acne Solutions)
Completed
- Acne Vulgaris
- +2 more
- MBI 226 Acne Solutions
- (no location specified)
Sep 13, 2005
Continuity of Care at a Health Service Organization
Completed
- Diabetes Mellitus
- Assessment of continuity of care from the patient perspective
- Relationship between continuity of care, patient outcomes, and costs
-
Sault Ste. Marie, Ontario, CanadaGroup Health Centre
Sep 13, 2005
Critical Ill Patients in SICU Trial in Taipei (Omegaven 10%)
Unknown status
- Critical Ill Patients in SICU
- Omegaven 10%
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 12, 2005